Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.

AUTOR(ES)

Politi, A.

RESUMO

Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).

Documentos Relacionados

• Atherosclerosis--reversal with therapy.
• Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
• Reversal of renovascular hypertension caused by nonspecific aortitis after corticosteroid therapy.
• Cardiomyopathy associated with high-dose interleukin-2 therapy.
• Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.